Diabetes Is a Major Risk Factor for Mortality After Lung Transplantation-Reference-Cited by-同舟云学术

Diabetes Is a Major Risk Factor for Mortality After Lung Transplantation

Published:2014-01-08 Issue:2 Volume:14 Page:438-445
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Hackman K. L.¹²,Bailey M. J.³,Snell G. I.¹⁴,Bach L. A.¹²

Affiliation:

1. Department of Medicine; Monash University; Melbourne Australia

2. Department of Endocrinology and Diabetes; The Alfred Hospital; Melbourne Australia

3. Department of Epidemiology and Preventative Medicine; Monash University; Melbourne Australia

4. Lung Transplant Service; The Alfred Hospital; Melbourne Australia

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.12561/fullpdf

Reference38 articles.

1. Australia and New Zealand Cardiothoracic Organ Transplant Registry Sixteenth Annual Report 2012. Available at http://www.anzcotr.org.au/uploadedFiles/1279001464281-56522.pdf

2. The Registry of the International Society for Heart, Lung Transplantation: 29th official adult heart transplant report-2012;Stehlik;J Heart Lung Transplant,2012

3. Clayton P Campbel S Hurst K McDonald S Chadban S. ANZDATA Registry Thirty Fourth Annual Report 2010 Adelaide: Australia and New Zealand Dialysis and Transplant registry; 2011. Available at http://www.anzdata.org.au/anzdata/AnzdataReport/34thReport/2011c08_transplantation_v1.7.pdf

4. ANZLT Registry Report 2010. Available at http://www.anzltr.org/thisYear/report.pdf

5. Diabetes mellitus after kidney transplantation in the United States;Kasiske;Am J Transplant,2003

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-Year Mortality After Lung Transplantation: Experience of a Single French Center Between 2012 and 2021;Annals of Transplantation;2024-06-24

2. Metformin attenuates lung ischemia-reperfusion injury and necroptosis through AMPK pathway in type 2 diabetic recipient rats;BMC Pulmonary Medicine;2024-05-14

3. Metabolic complications in lung transplantation for cystic fibrosis - A case control study;Heliyon;2024-05

4. SHIFTing goals in cystic fibrosis—managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium;Pediatric Pulmonology;2024-04-12

5. Favorable effect of CD26/DPP-4 inhibitors on postoperative outcomes after lung transplantation: A propensity-weighted analysis;The Journal of Heart and Lung Transplantation;2024-01